Fluid therapy in intra-cranial surgeries
Phase 1
Not yet recruiting
- Conditions
- Anaesthesia
- Registration Number
- PACTR201902530245620
- Lead Sponsor
- Tanta University Hospitals
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
Age more than 21 years.
Patients with GCS 15 (fully conscious).
ASA physical status II or III.
Exclusion Criteria
Patients refuse to participate in our study.
Patients with BMI more than 35 or less than 25.
Patients with cardiac arrhythmia (limitation to use stroke volume variation as an indicator of fluid responsiveness).
Significant renal dysfunction (serum creatinine > 1.5 mg/dl).
Severe heart failure (New York Heart Association classification 3 or 4).
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ICU length of stay
- Secondary Outcome Measures
Name Time Method Postoperative complication
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie Cardiometry-guided fluid management in improving cerebral perfusion during intracranial surgeries?
How does Cardiometry-guided fluid therapy compare to standard-of-care approaches in reducing postoperative neurological complications in intracranial surgery patients?
Which biomarkers predict optimal response to Cardiometry-guided fluid management in patients undergoing intracranial procedures under general anesthesia?
What are the potential adverse events associated with Cardiometry-guided fluid administration during intracranial surgeries and how are they managed?
Are there combination approaches involving Cardiometry-guided fluid therapy and other anesthetic techniques to enhance outcomes in intracranial surgery?